Duff & Phelps Advised Comprehensive Clinical Development on the Sale of its Early Development Division to Actavis, Inc.
In July 2013, Comprehensive Clinical Development (CCD) sold its Early Development Division to Actavis, Inc. (Actavis).
About Comprehensive Clinical Development
Comprehensive Clinical Development is a clinical research company focusing on clinical pharmacology, central nervous system (CNS) and oncology trials. CCD’s Early Development Division, operating out of a state-of-the-art clinical research facility in Miramar, Florida, has significant expertise in complex Phase I - IIa studies and maintains a sizable database of well-characterized healthy volunteers and disease state special populations.
About Actavis, Inc.
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Actavis has global headquarters in Parsippany, New Jersey and has operations in over 60 countries.
Duff & Phelps acted as the exclusive financial advisor to CCD in connection with CCD’s §363 sale process pursuant to the U.S. Bankruptcy Code and provided M&A advisory services in connection with the sale of CCD’s Early Development Division to Actavis.